Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

The pharmacogenomics journal, 2005 - nature.com
CYP2D6 is of great importance for the metabolism of clinically used drugs and about 20–
25% of those are metabolised by this enzyme. In addition, the enzyme utilises …
被引用次数：1414 相关文章

[引用][C] GENETIC POLYMORPHISMS OF CYTOCHROME P450 2D6 (CYP2D6): CLINICAL CONSEQUENCES, EVOLUTIONARY ASPECTS AND FUNCTIONAL …

SM INGELMAN - 2005 - sid.ir

Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

M Ingelman-Sundberg - The pharmacogenomics journal, 2005 - pubmed.ncbi.nlm.nih.gov
CYP2D6 is of great importance for the metabolism of clinically used drugs and about 20-
25% of those are metabolised by this enzyme. In addition, the enzyme utilises …

Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

M Ingelman-Sundberg - The Pharmacogenomics Journal, 2005 - go.gale.com
CYP2D6 is of great importance for the metabolism of clinically used drugs and about 20-
25% of those are metabolised by this enzyme. In addition, the enzyme utilises …

Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity.

M Ingelman-Sundberg - The Pharmacogenomics Journal, 2005 - europepmc.org
CYP2D6 is of great importance for the metabolism of clinically used drugs and about 20-
25% of those are metabolised by this enzyme. In addition, the enzyme utilises …

[引用][C] Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

M INGELMAN-SUNDBERG - Pharmacogenomics J., 2005 - cir.nii.ac.jp
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6) : clinical consequences,
evolutionary aspects and functional diversity | CiNii Research CiNii 国立情報学研究所 学術 …

Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity.

M Ingelman-Sundberg - Pharmacogenomics Journal, 2005 - search.ebscohost.com
CYP2D6 is of great importance for the metabolism of clinically used drugs and about 20-
25% of those are metabolised by this enzyme. In addition, the enzyme utilises …

[引用][C] Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

M INGELMAN-SUNDBERG - Pharmacogenomics J., 2005 - cir.nii.ac.jp
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6) : clinical consequences,
evolutionary aspects and functional diversity | CiNii Research CiNii 国立情報学研究所 学術情報 …

[引用][C] GENETIC POLYMORPHISMS OF CYTOCHROME P450 2D6 (CYP2D6): CLINICAL CONSEQUENCES, EVOLUTIONARY ASPECTS AND FUNCTIONAL …

SM INGELMAN - 2005 - sid.ir

[引用][C] Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

M Ingelman-Sundberg - The Pharmacogenomics Journal, 2005 - Nature Publishing Group